Date published: 2026-5-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

Histone cluster 1 H2AA Inhibitors

Histone cluster 1 H2AA Inhibitors pertain to a specialized class of chemical compounds designed to selectively impede the activity of histone cluster 1, subtype H2AA. Histones are essential proteins that contribute to the structural organization of DNA in the cell nucleus, forming nucleosomes around which DNA is wound. The H2AA subtype specifically denotes a variant of histone H2A, one of the core histones involved in nucleosome formation. The H2A family of histones plays a fundamental role in regulating gene expression and chromatin structure. Inhibitors targeting Histone cluster 1 H2AA are likely designed to interact with specific regions of this histone variant, influencing its interactions with DNA and other proteins, and potentially modulating chromatin dynamics.

The development of Histone cluster 1 H2AA Inhibitors requires a nuanced understanding of the structural characteristics of histone H2AA and its role within chromatin architecture. These inhibitors are meticulously crafted for specificity, aiming to selectively bind to key regions of Histone cluster 1 H2AA and interfere with its normal functions. By employing Histone cluster 1 H2AA Inhibitors in experimental settings, researchers can delve into the consequences of inhibiting this specific histone variant, unraveling insights into chromatin remodeling and gene regulation. The study of histones and their variants, including H2AA, is central to our comprehension of epigenetic mechanisms, shedding light on the dynamic processes that control gene expression and contribute to the complex orchestration of cellular functions.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

RGFP966

1357389-11-7sc-507300
5 mg
$115.00
(0)

RGFP966 inhibits histone deacetylase, altering chromatin structure and potentially modulating the transcription of genes, including Histone cluster 1 H2AA.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$90.00
$212.00
24
(2)

MS-275 is a histone deacetylase inhibitor, influencing gene expression by preventing the removal of acetyl groups from histones, including H2AA.

UNC1999

1431612-23-5sc-475314
5 mg
$142.00
1
(0)

UNC1999 targets the methyltransferase activity of histone methyltransferase, possibly impacting the methylation status and expression of H2AA.

SGC-CBP30

1613695-14-9sc-473871
sc-473871A
5 mg
10 mg
$178.00
$338.00
(0)

SGC-CBP30 inhibits the bromodomain of CBP, disrupting acetylated histone recognition and potentially affecting the transcriptional regulation of H2AA.

GSK-J4

1373423-53-0sc-507551
100 mg
$1275.00
(0)

GSK-J4 inhibits lysine demethylase, potentially influencing the demethylation status of histones and the transcription of genes, including H2AA.

EPZ6438

1403254-99-8sc-507456
1 mg
$66.00
(0)

EPZ-6438 targets EZH2, a histone methyltransferase, potentially impacting the methylation of histones and the expression of genes like H2AA.

Scriptaid

287383-59-9sc-202807
sc-202807A
1 mg
5 mg
$64.00
$183.00
11
(2)

Scriptaid is a histone deacetylase inhibitor, modulating chromatin structure and potentially affecting the expression of genes, including H2AA.

GSK343

1346704-33-3sc-397025
sc-397025A
5 mg
25 mg
$151.00
$461.00
1
(0)

GSK343 inhibits EZH2, potentially influencing histone methylation patterns and the transcriptional regulation of genes, including Histone cluster 1 H2AA.

PF 4708671

1255517-76-0sc-361288
sc-361288A
10 mg
50 mg
$179.00
$700.00
9
(1)

UNC0638 inhibits G9a, a histone methyltransferase, potentially influencing the methylation status of histones and the expression of genes, including H2AA.